Discussion
In this report, we present data on antibody modulation of Spike-monocyte interactions. To the best of our knowledge, only one previously published report showed Spike-bead phagocytosis after opsonization with 50% heat-inactivated serum and a 16 hours incubation of beads with THP-1 cells (22). We believe that the data from our experiments are more representative of the first few events after Spike-monocyte contact. Phagocytosis of small particles such as virions is a process that takes minutes, not hours (27). That is why we use shorter incubation times (30 min) and perform dose-response analysis across varying plasma concentrations. The dose-response analysis we performed exposed an antibody-mediated modulation of the Spike-monocyte interactions. It is important to elaborate on the concentrations we utilized, be it for plasma or monoclonal antibodies. For plasma, as tissues have a lower concentration of plasma proteins than whole blood, we used 1% as the highest concentration. As for the monoclonal antibody concentrations, we used 100 µg/ml as the highest concentration because it is roughly 1% of the antibody concentration present in plasma (10 mg/ml). Even though most of the experiments in this study are performed in vitro, we believe the effects we observe on phagocytosis could also be relevant in vivo, as the modulation effects occur already at relatively low antibody concentrations and would thus cover many physiological niches and scenarios.
That an increased binding of antibodies to a prey results in reduced or blocked phagocytosis is in stark contrast to what is typically expected (28). It cannot be explained by specific monoclonal interactions, as it is seen across diverse monoclonals as well as in convalescent polyclonal samples. This block in phagocytosis is only related to Spike protein. A combination of known mechanisms could potentially explain how SARS-CoV-2 could avoid phagocytosis using Spike protein. Bivalent trans-binding of antibodies is known to promote virion phagocytosis (29), where antigens are cross-linked depending on their density at the surface. Spike protein density on SARS-CoV-2 varies (30), and is increased with the D614G mutation (31). An increase in Spike anti-body levels would lead to a competition of epitope binding, ultimately favoring the switch from bivalent trans-binding to monovalent binding, potentially leading to a reduction in phagocytosis. A synergistic mechanism could further aid SARS-CoV-2. Antigen height (especially below 10 nm) is important for efficient phagocytosis (32), and most likely, a consistent antigen height is beneficial as well. Besides altering its density, SARS-CoV-2 also appears to be able to dramatically change the Spike protein conformation, where some proteins stand up vertically from the surface, and others are tilted down horizontally (30). At high anti-Spike levels, this would present an approaching phagocyte with a monovalently opsonized, irregular surface with variable antigen height (15-25 nm), making the interaction difficult. In contrast, at low anti-Spike levels, the antibodies would be able to clasp Spike proteins in a bivalent, upright manner, presenting the phagocyte with a coherently opsonized surface at an effectively low antigen height. Careful mechanistic studies are needed to test this hypothesis…
https://www.biorxiv.org/content/10.1101/2021.10.14.464464v1.full